DEL DUCA, Ester
 Distribuzione geografica
Continente #
NA - Nord America 200
AS - Asia 101
EU - Europa 94
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 401
Nazione #
US - Stati Uniti d'America 194
SG - Singapore 81
IT - Italia 47
SE - Svezia 13
IN - India 10
IE - Irlanda 9
GB - Regno Unito 6
CN - Cina 5
BG - Bulgaria 4
MX - Messico 4
BE - Belgio 3
FI - Finlandia 3
HK - Hong Kong 3
BR - Brasile 2
CA - Canada 2
DE - Germania 2
PH - Filippine 2
AR - Argentina 1
AU - Australia 1
CI - Costa d'Avorio 1
FR - Francia 1
MD - Moldavia 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
TG - Togo 1
UA - Ucraina 1
Totale 401
Città #
Singapore 36
Fairfield 31
Chandler 23
Rome 20
Ashburn 18
Woodbridge 13
Seattle 12
Houston 11
Dublin 9
Milan 7
Wilmington 7
Cambridge 6
Ann Arbor 5
San Diego 5
San Paolo di Civitate 5
Beijing 4
Lawrence 4
London 4
Princeton 4
Sofia 4
Brussels 3
Hong Kong 3
New York 3
Boston 2
Bremen 2
Fiumicino 2
Millbury 2
Mumbai 2
Naples 2
Plano 2
San Donato Milanese 2
Santa Maria 2
West Jordan 2
Abidjan 1
Americana 1
Amsterdam 1
Andover 1
Bhopal 1
Boardman 1
Carugate 1
Castelforte 1
Chehalis 1
Coimbatore 1
Council Bluffs 1
Federal 1
Florence 1
Gdansk 1
Hackney 1
Helsinki 1
Las Vegas 1
Lomé 1
Los Angeles 1
Oslo 1
Ottawa 1
Prescot 1
Sydney 1
São Paulo 1
Toronto 1
Totale 282
Nome #
Cutaneous manifestations in antiphospholipid syndrome 98
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 85
Psa-disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients. An italian derma-rheuma multicentre study 50
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption 34
Atopic dermatitis and ulcerative colitis successfully treated with upadacitinib 11
Long-term follow-up for q-switched nd:yag treatment of nevus of ota. are high number of treatments really required? a case report 10
Proteomic analysis from skin swabs reveals a new set of proteins identifying skin impairment in Atopic Dermatitis 9
Histological skin changes after treatment with 675 nm laser 9
Nanosecond Q-switched 1064/532 nm laser to treat hyperpigmentations. a double center retrospective study 8
The evolving landscape of biologic therapies for atopic dermatitis. present and future perspective 8
Nd:YAG laser in association with pulsed dye laser for the treatment of PHACES syndrome 8
Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate and 3.75% imiquimod in the treatment of actinic keratosis 7
Blue light-emitting diodes in hair regrowth. the first prospective study 7
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab 7
Ablative fractional laser improves treatment of actinic keratoses with ingenol mebutate 6
Nonconventional use of flash-lamp pulsed-dye laser in dermatology 6
Q-switched 1064/532 nm laser with nanosecond pulse in tattoo treatment. a double-center retrospective study 6
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 6
308 nm UV excimer light in monotherapy or combined to topical khellin 4% and/or tacrolimus 0.1% in the treatment of vitiligo 6
Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis. a single-centre, observational, retrospective, real-life study 6
Age of onset defines two distinct profiles of atopic dermatitis in adults 6
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis. results from an italian multicenter study 6
Reducing the oral isotretinoin skin side effects. efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients 6
A new 675-nm laser device in the treatment of acne scars. an observational study 6
Daylight photodynamic therapy with 5-aminolevulinic acid 5% gel for the treatment of mild-to-moderate inflammatory acne 6
Management of laser treatments during the coronavirus disease 2019 pandemic. the italian experience 5
Diversity of atopic dermatitis and selection of immune targets 5
Transcriptomic profiling of tape-strips from moderate to severe atopic dermatitis patients treated with dupilumab 5
Safety evaluation of apremilast for the treatment of psoriasis 5
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases 5
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement 5
TFOS lifestyle. Impact of cosmetics on the ocular surface 5
Combined CO2 and dye laser technique in the treatment of outcomes due to flap necrosis after surgery for basal cell carcinoma on the nose 5
Arsenic and chromium levels in hair correlate with actinic keratosis/non melanoma skin cancer. results of an observational controlled study 5
Distinct skin microbiome community structures in congenital ichthyosis 5
Cytokine pathways and investigational target therapies in hidradenitis suppurativa 5
Telomere and telomerase modulation by bergamot polyphenolic fraction in experimental photoageing in human keratinocytes 5
Proteomic characterization of atopic dermatitis blood from infancy to adulthood 5
Long-pulsed 755-nm alexandrite laser equipped with a sapphire handpiece. unwanted hair removal in darker phototypes 5
Fractional CO2 laser. from skin rejuvenation to vulvo-vaginal reshaping 5
Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw 5
Proteomic signatures of inflammatory skin diseases. a focus on atopic dermatitis 4
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers 4
Cutaneous body image in psoriasis. the role of attachment style and alexithymia 4
UVA1 laser in the treatment of vitiligo 4
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis 4
Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals 4
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis 4
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis 4
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults 4
Efficacy of vismodegib in pigmented basal cell carcinoma. appearances are deceiving 4
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin 4
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. a two-center. prospective assessor-blinded, proof-of-concept study 4
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity 4
Frontal fibrosing alopecia shows robust T helper 1 and janus kinase 3 skewing 4
Pharmacoeconomy of drugs used in the treatment of actinic keratoses 4
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body. pilot study in skin types IV–VI 4
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies 4
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin 4
Long-pulsed 1064-nm Nd:YAG laser for the treatment of onychomycosis 4
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis 4
Repurposing DPP4 inhibition to improve hair follicle activation and regeneration 4
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis 4
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities 4
Alopecia areata. current treatments and new directions 4
Cutaneous mastocytosis. a dermatological perspective 4
Potential applications of topical oxygen therapy in dermatology 4
Transcriptomic analysis of the major orphan ichthyosis subtypes reveals shared immune and barrier signatures 4
Drugs for the treatment of chronic hand eczema. successes and key challenges 4
Association between psoriasis and periodontitis, and efficacy of anti-TNF-α therapy 4
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities 4
Update of calcineurin inhibitors to treat inverse psoriasis. a systematic review 4
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo 4
Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients 4
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis 4
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata 4
Treat-to-target in dermatology. a scoping review and international eczema council survey on the approach in atopic dermatitis 4
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases 4
Hyperactivation of the JAK2/STAT5 signaling pathway and evaluation of baricitinib treatment among patients with eosinophilic cellulitis 4
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata 4
SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age 4
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata 4
RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22, and JAK3-skewing 4
A case of pincer nail successfully treated with tazarotene 0.1% gel 4
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis 3
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways 3
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma 3
Immune and barrier characterization of atopic dermatitis skin phenotype in tanzanian patients 3
The translational revolution in atopic dermatitis. the paradigm shift from pathogenesis to treatment 3
Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations 2
Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling 2
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI. a randomized split-body pilot study 2
Proteomic alterations in patients with atopic dermatitis 2
Skin tape-strips in old order Mennonite toddlers reveal upregulated barrier markers and low T-helper inflammatory tone 2
Totale 694
Categoria #
all - tutte 3.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 7 1 0 2 3 4 5 4 4 4 2 6
2020/202137 3 4 0 0 0 0 0 2 10 18 0 0
2021/202249 0 5 2 1 4 2 5 3 3 3 13 8
2022/202379 9 17 7 10 5 8 0 7 10 1 5 0
2023/2024427 1 1 92 10 15 9 3 6 2 21 16 251
2024/202521 21 0 0 0 0 0 0 0 0 0 0 0
Totale 694